Education
About Us
Working with TipRanks
Follow Us
Oncolytics Biotech (TSE:ONC)
TSX:ONC
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | C$ 0.00 | C$ 0.00 | C$ 0.00 | C$ 0.00 | C$ 0.00 |
| Gross Profit | C$ 0.00 | C$ -403.00K | C$ -392.00K | C$ -452.06K | C$ -446.19K |
| Operating Income | C$ -34.98M | C$ -33.79M | C$ -28.57M | C$ -26.23M | C$ -25.46M |
| EBITDA | C$ -34.88M | C$ -33.71M | C$ -26.83M | C$ -25.80M | C$ -25.37M |
| Net Income | C$ -31.71M | C$ -27.75M | C$ -24.84M | C$ -26.30M | C$ -19.55M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | C$ 15.94M | C$ 34.91M | C$ 32.14M | C$ 41.26M | C$ 31.22M |
| Total Assets | C$ 20.19M | C$ 38.82M | C$ 37.33M | C$ 45.88M | C$ 34.35M |
| Total Debt | C$ 1.06M | C$ 423.00K | C$ 373.00K | C$ 654.75K | C$ 402.06K |
| Net Debt | C$ -14.88M | C$ -34.49M | C$ -11.29M | C$ -40.61M | C$ -30.82M |
| Total Liabilities | C$ 14.20M | C$ 11.26M | C$ 10.83M | C$ 9.78M | C$ 9.59M |
| Stockholders' Equity | C$ 5.98M | C$ 27.56M | C$ 26.50M | C$ 36.10M | C$ 24.75M |
| Cash Flow | |||||
| Free Cash Flow | C$ -27.20M | C$ -28.46M | C$ -23.41M | C$ -22.72M | C$ -22.10M |
| Operating Cash Flow | C$ -26.97M | C$ -28.45M | C$ -23.36M | C$ -22.43M | C$ -22.07M |
| Investing Cash Flow | C$ -239.00K | C$ 20.22M | C$ -20.40M | C$ -285.95K | C$ -29.30K |
| Financing Cash Flow | C$ 6.64M | C$ 31.99M | C$ 12.21M | C$ 33.02M | C$ 39.77M |